Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1993 Feb 15;90(4):1571-5.
doi: 10.1073/pnas.90.4.1571.

Electrostatic interactions modulate the RNA-binding and transactivation specificities of the human immunodeficiency virus and simian immunodeficiency virus Tat proteins

Affiliations
Comparative Study

Electrostatic interactions modulate the RNA-binding and transactivation specificities of the human immunodeficiency virus and simian immunodeficiency virus Tat proteins

J Tao et al. Proc Natl Acad Sci U S A. .

Abstract

The transcriptional activating (Tat) proteins from human immunodeficiency virus and simian immunodeficiency virus are sequence-specific RNA-binding proteins. In human immunodeficiency virus Tat, a single arginine residue, flanked on each side by three to four basic amino acids, mediates specific binding to a bulge region in trans-acting responsive element (TAR) RNA. We have systematically mutated the flanking charged residues and found that, in addition to the position of the sequence-specific arginine, the particular arrangement of nonspecific electrostatic interactions is an important determinant of RNA-binding specificity and transactivation activity. These additional electrostatic contacts may help stabilize the structure of TAR RNA when bound to arginine. One critical electrostatic interaction, located two residues N-terminal to the arginine, is absent in the simian immunodeficiency virus Tat protein and accounts for the difference in promoter specificities of the human and simian immunodeficiency viral proteins.

PubMed Disclaimer

References

    1. Curr Opin Genet Dev. 1992 Apr;2(2):293-8 - PubMed
    1. Science. 1992 Jul 3;257(5066):76-80 - PubMed
    1. Science. 1985 Jan 11;227(4683):171-3 - PubMed
    1. EMBO J. 1987 Dec 1;6(12):3755-60 - PubMed
    1. J Virol. 1988 Dec;62(12):4523-32 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources